Research use only. All products are supplied strictly for laboratory research purposes — not for human or veterinary consumption.

GLOW 70mg Research Blend

GLOW is a three-component research blend supplied in a single 3mL pen: GHK-Cu, BPC-157 and TB-500. It is intended for laboratory research use only, and the sections below describe each component separately rather than making any claim about the combination.

Specification

  • Presentation: 70mg — GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
  • Price: £130
  • Evidence status: Predominantly preclinical; no clinical trials of the combination

Components

  • GHK-Cu 50mg — Copper-binding tripeptide studied in dermal matrix and collagen research.
  • BPC-157 10mg — Pentadecapeptide derived from a sequence identified in gastric juice.
  • TB-500 10mg — Synthetic fragment corresponding to the actin-binding region of thymosin β4.

Research background

GLOW combines three peptides that are each studied in connection with tissue and extracellular matrix research. They are supplied together as a convenience for laboratories running combination work, which would otherwise require three separate reconstitutions and transfers.

It is worth being precise about what is and is not known here. Each of the three components has its own research literature of varying depth. The combination itself has not been the subject of controlled study, so no conclusion about the blend as a whole can be drawn from the individual component literature.

GHK-Cu has the most developed evidence base of the three, including topical formulation work. BPC-157 and TB-500 are studied almost entirely in preclinical models.

Pathways under investigation

GHK-Cu and the copper-binding tripeptide pathway

GHK (glycyl-L-histidyl-L-lysine) is a tripeptide found naturally in human plasma that binds copper(II) with high affinity. Reported plasma levels decline with age. Research interest centres on its interaction with extracellular matrix components and on copper transport, studied largely in cell culture and in topical formulation work.

BPC-157 and cytoprotection models

BPC-157 corresponds to a partial sequence of a protein identified in gastric juice. Preclinical work has examined angiogenic signalling and cell migration in cultured tissue and rodent models. Human evidence is absent.

TB-500 and actin binding

TB-500 corresponds to the actin-binding region of thymosin β4, a protein present in most mammalian cell types. Research focuses on actin polymerisation and cell motility assays.

Research and regulatory status

  • None of the three components holds a marketing authorisation as a medicine in the United Kingdom.
  • GHK-Cu appears as an ingredient in cosmetic formulation research and in some topical products; that regulatory position is distinct from any systemic use.
  • BPC-157 and TB-500 both appear on the World Anti-Doping Agency prohibited list, which is relevant to anyone working in a sport-related research context.
  • The combination has not been evaluated in controlled clinical study. Supplied for in-vitro laboratory research only.

Analytical testing and certificates of analysis

Batch documentation for GLOW is available on request where we hold it. We do not publish a public batch database, and no purity, identity, sterility or manufacturing claim is stated anywhere on this site unless documentation for that exact batch supports it. To ask what is held for a particular lot, contact us.

References and further reading

These are starting points for your own reading, not endorsements of any conclusion.

Frequently asked questions

What is in GLOW?

A single 3mL pen containing 70mg in total: GHK-Cu 50mg, BPC-157 10mg and TB-500 10mg.

How does GLOW differ from KLOW?

KLOW is the same three peptides with KPV 10mg added, giving 80mg total. The GHK-Cu, BPC-157 and TB-500 amounts are identical in both.

Has the combination been studied?

No. The individual components each have their own literature, but the blend as a combination has not been the subject of controlled study. We do not extrapolate from one to the other.

Why is GHK-Cu blue?

The characteristic blue colour comes from the coordinated copper(II) ion in the GHK-copper complex. It is a property of the molecule, not an additive.

Related research

Related compounds

Research use only

This product is supplied strictly for in-vitro laboratory research. It is not a medicine, is not licensed by the MHRA, and is not for human or veterinary consumption or administration. We do not supply dosing, reconstitution or administration guidance, and nothing on this page is a therapeutic claim.